The US FDA has granted approval to Nyxoah’s Genio system for treating individuals with moderate to severe obstructive sleep apnoea (OSA).

UK-based EDX Medical has developed a test designed to identify and characterise the early signs of pneumonia in critically ill hospitalised patients.

Dana-Farber Cancer Institute has unveiled a new blood test that could change the way multiple myeloma (MM) and its precursor conditions.

China's NMPA has approved Bracco Imaging's ultrasound contrast agent, sulphur hexafluoride (SF6) microbubbles.

Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based CRC screening test in the US.

BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.

Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA).

HistoSonics has announced a majority stake acquisition by a consortium involving a transaction that values the company at $2.25bn.

Natera has introduced a non-invasive prenatal test (NIPT), Fetal Focus, specifically designed for inherited conditions. According to the company, when a pregnant individual is found to carry a ...

Medical Device Network sat down with Dexcom's outgoing CEO Kevin Sayer to learn more about how the company will maintain its market position and drive innovation in the CGM space in the future.

MedTech Europe has reiterated the importance of tariff-free trade for medical technologies following the US decision to impose reciprocal tariffs of 15% on most goods from Europe.

The upcoming EpiPen patent expiration on 11 September 2025 sets the stage for a pivotal shift in the epinephrine delivery market.